Episode 8 – Patient conversations part one: the neurologist perspective

In Episode 8 of the Illuminoz podcast series, Bianca Stadler speaks with Dr. Agnė Straukienė – neurologist and MS service lead in the UK – about how to approach treatment-related conversations with patients, especially when introducing or switching to a biosimilar.

What concerns do patients commonly raise? How can complex topics be explained clearly and empathetically? And how can clinicians address the nocebo effect while supporting shared decision-making?

This episode offers practical communication strategies, helpful analogies, and a patient-centered approach to navigating biosimilar discussions in MS care.